Immunity for health is pleased to welcome Dieter Vancraeynest as a new member of its Board of Directors. Dieter joins the Board as a representative of Zoetis, the world’s leading animal health company, and brings with him over two decades of experience in veterinary innovation, global leadership, and external partnership development.
💡 A career built on innovation and impact
Dieter is currently External Innovation Lead at Zoetis, where he drives the identification and integration of cutting-edge technologies and collaborations to strengthen the company’s global R&D pipeline. He has a proven track record in aligning scientific insight with commercial strategy, guiding product ideation, valuation, and lifecycle development.
Since joining Zoetis in 2013, Dieter has held multiple leadership roles, including Senior Director of Global Commercial Development for Poultry and Aquaculture and Group Director for Poultry in Europe, Africa, and the Middle East. Prior to that, he worked at Pfizer Animal Health, Alpharma, and Orafti, with a focus on poultry health, intestinal health, and prebiotic research.Dieter is a trained veterinarian and holds a PhD in Veterinary Sciences from Ghent University.
🌍 Strengthening Immunity for health with a One Health perspective
With a strong background in animal health innovation, Dieter brings a valuable perspective to the Board of Directors. His work focuses on advancing veterinary solutions that improve animal health, while fully recognising their relevance to public health through the One Health approach. This vision aligns closely with Immunity for health’s mission to foster innovation and stimulate the development of vaccines and immunotherapies, contributing to better health for both humans and animals.
We look forward to Dieter’s contribution to our growing ecosystem, and to the insights he will bring as we continue to build bridges between academia, industry, and public health.
